先声药业“老树开新芽”,诸多重磅产品即将登场

药渡
05 May

作为中国最早一批从仿制药企成功转型为创新驱动型的代表,先声药业在过去的几年中创新药收入占比不断创出新高。在全球医药行业风云变幻的浪潮中,先声药业虽然作为老牌药企,曾经走了些弯路,但在其独特的创新理念和坚定的发展战略经营下,如今已然“凶相毕露”,不愧是从蛮荒时代过来的“狠人”。在当前创新为王的时代,先声药业已站稳脚跟无疑,未来只剩下飞得多高的问题而已。创新比例再创新高若要追溯起历史,先声药业可谓是跟...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10